These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 38699691)

  • 1. 2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.
    Byrne RA; Fremes S; Capodanno D; Czerny M; Doenst T; Emberson JR; Falk V; Gaudino M; McMurray JJV; Mehran R; Milojevic M; Uva MS
    Eur J Cardiothorac Surg; 2023 Aug; 64(2):. PubMed ID: 37632766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between SUA and prognosis in CHF patients after revascularization.
    Miao B; Wu J; Jiao W; Yanxin L; Da Y; Dong W; Gao B
    J Med Biochem; 2024 Apr; 43(2):193-199. PubMed ID: 38699691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictive value of hemoglobin to serum creatinine ratio combined with serum uric acid for in-hospital mortality after emergency percutaneous coronary intervention in patients with acute myocardial infarction].
    Bao F; Yang C; Zhou G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Sep; 35(9):951-957. PubMed ID: 37803954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated postoperative serum uric acid is associated with major adverse events following coronary artery bypass grafting.
    Shi Y; Zhang X; Du J; Chen S; Zhang H; Yang L; Zheng Z
    J Card Surg; 2020 Oct; 35(10):2559-2566. PubMed ID: 33043654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study.
    Zhang S; Liu X; Song B; Yu H; Zhang X; Shao Y
    BMJ Open; 2022 Jan; 12(1):e052031. PubMed ID: 35022171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 7. The Relationship Between Serum Uric Acid at Different Concentrations of Lipid Indices and the Risk of Myocardial Revascularization in Patients With Acute Coronary Syndrome: A Retrospective Analysis.
    Lin Y; Hidru TH; Fan R; Gao J; Li H; Yang X; Xia Y
    Front Cardiovasc Med; 2021; 8():732715. PubMed ID: 34497839
    [No Abstract]   [Full Text] [Related]  

  • 8. Associations of serum high-sensitivity C-reactive protein and prealbumin with coronary vessels stenosis determined by coronary angiography and heart failure in patients with myocardial infarction.
    Zhu Y; Yu Z; Xu R; Wang B; Lou Y; Zhang N; Chen Z
    J Med Biochem; 2023 Jan; 42(1):9-15. PubMed ID: 36819129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases.
    Heidecker B; Dagan N; Balicer R; Eriksson U; Rosano G; Coats A; Tschöpe C; Kelle S; Poland GA; Frustaci A; Klingel K; Martin P; Hare JM; Cooper LT; Pantazis A; Imazio M; Prasad S; Lüscher TF
    Eur J Heart Fail; 2022 Nov; 24(11):2000-2018. PubMed ID: 36065751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A predictive model involving serum uric acid, C-reactive protein, diabetes, hypercholesteremia, multiple lesions for restenosis risk in everolimus-eluting stent-treated coronary heart disease patients.
    Feng Q; Zhao Y; Wang H; Zhao J; Wang X; Shi J
    Front Cardiovasc Med; 2022; 9():857922. PubMed ID: 36035940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.
    Doehner W; Anker SD; Butler J; Zannad F; Filippatos G; Ferreira JP; Salsali A; Kaempfer C; Brueckmann M; Pocock SJ; Januzzi JL; Packer M
    Eur Heart J; 2022 Sep; 43(36):3435-3446. PubMed ID: 35788657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Serum Uric Acid and Cardiovascular Disease: A Review and Potential Therapeutic Interventions.
    Freilich M; Arredondo A; Zonnoor SL; McFarlane IM
    Cureus; 2022 Mar; 14(3):e23582. PubMed ID: 35494989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical study of Shen Qi Li Xin formula in improving the development of chronic heart failure.
    Sui YB; Zhang KK; Ling LY; Fan R; Liu L
    Histol Histopathol; 2022 Aug; 37(8):803-812. PubMed ID: 35333374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Mantovani A; Bonapace S; Dugo C; Beatrice G; Petracca G; Cappelli D; Csermely A; Molon G; Targher G
    Int J Cardiol; 2022 Apr; 353():127-130. PubMed ID: 35167908
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.